These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 9666526

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Transcutaneous measures of oxygen partial pressure and capillaroscopic parameters as affected by naftidrofuryl in patients with obliterative arteriopathies, Fontaine stages II-IV].
    Ranft J, Heidrich H, Lammersen T.
    J Mal Vasc; 1987; 12(1):78-81. PubMed ID: 3559415
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Cost effectiveness of cilostazol compared with naftidrofuryl and pentoxifylline in the treatment of intermittent claudication in the UK.
    Guest JF, Davie AM, Clegg JP.
    Curr Med Res Opin; 2005 Jun; 21(6):817-26. PubMed ID: 15969881
    [Abstract] [Full Text] [Related]

  • 27. [Evaluation of cutaneous necrosis risk in peripheral arterial diseases].
    D'Eri A, Martini R, Cordova RM, Trevisan G, Andreozzi GM.
    Minerva Cardioangiol; 2002 Jun; 50(3):239-44. PubMed ID: 12107403
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Comparison of whole-body thallium imaging with transcutaneous PO2 in studying regional blood supply in patients with peripheral arterial occlusive disease.
    Liu Y, Steinacker JM, Opitz-Gress A, Clausen M, Stauch M.
    Angiology; 1996 Sep; 47(9):879-86. PubMed ID: 8810654
    [Abstract] [Full Text] [Related]

  • 30. The effects of cilostazol on exercise-induced ischaemia-reperfusion injury in patients with peripheral arterial disease.
    O'Donnell ME, Badger SA, Sharif MA, Makar RR, McEneny J, Young IS, Lee B, Soong CV.
    Eur J Vasc Endovasc Surg; 2009 Mar; 37(3):326-35. PubMed ID: 19112032
    [Abstract] [Full Text] [Related]

  • 31. Transcutaneous measurement of oxygen and carbon dioxide tension (TcPO2 and TcPCO2) during treadmill exercise in patients with arterial occlusive disease (AOD)--stages I and II.
    Schmidt JA, Bracht C, Leyhe A, von Wichert P.
    Angiology; 1990 Jul; 41(7):547-52. PubMed ID: 2389836
    [Abstract] [Full Text] [Related]

  • 32. [Naftidrofuryl in arterial occlusive disease. Controlled multicenter double-blind study with oral administration].
    Maass U, Amberger HG, Böhme H, Diehm C, Dimroth H, Heidrich H, Heinrich F, Hirche H, Mörl H, Müller-Bühl U.
    Dtsch Med Wochenschr; 1984 May 11; 109(19):745-50. PubMed ID: 6373217
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. A controlled trial of naftidrofuryl (Praxilene) in the treatment of intermittent claudication.
    Clyne CA, Galland RB, Fox MJ, Gustave R, Jantet GH, Jamieson CW.
    Br J Surg; 1980 May 11; 67(5):347-8. PubMed ID: 6992909
    [Abstract] [Full Text] [Related]

  • 36. [Evaluation of the efficacy and tolerance of naftidrofuryl in patients presenting with exertional angina. Multicenter double-blind versus placebo study].
    Hirsch JL, Bensoussan JJ, Mosnier M, Lehert P.
    Ann Cardiol Angeiol (Paris); 1999 Feb 11; 48(2):137-45. PubMed ID: 12555338
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Oral naftidrofuryl. A review of its pharmacology and therapeutic use in the management of peripheral occlusive arterial disease.
    Barradell LB, Brogden RN.
    Drugs Aging; 1996 Apr 11; 8(4):299-322. PubMed ID: 8920176
    [Abstract] [Full Text] [Related]

  • 39. Naftidrofuryl in chronic arterial disease. Results of a controlled multicenter study.
    Trübestein G, Böhme H, Heidrich H, Heinrich F, Hirche H, Maass U, Mörl H, Rudofsky G.
    Angiology; 1984 Nov 11; 35(11):701-8. PubMed ID: 6388425
    [Abstract] [Full Text] [Related]

  • 40. Effects of regular physical training in a supervised class and additional intravenous prostaglandin E1 and naftidrofuryl infusion therapy in patients with intermittent claudication--a controlled study.
    Diehm C, Kühn A, Strauss R, Hübsch-Müller C, Kübler W.
    Vasa Suppl; 1989 Nov 11; 28():26-30. PubMed ID: 2609241
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.